CHEK1 and lung adenocarcinoma: In addition, promoter methylation, amplification, and miRNA regulation in patients with lung adenocarcinoma may lead to the upregulation of the CHEK1 gene, which may be a marker for predicting the survival rate of patients with lung adenocarcinoma [65].